“Dr. Bourne’s experience in analysis, in addition to his give attention to IP technique, licensing, and enterprise growth, will show invaluable at this pivotal level in BirchBioMed’s growth,” mentioned Mark S. Miller, BirchBioMed Chairman and CEO. “As Director of Biophysics for Serometrix LLC, Dr. Bourne led the corporate’s biology and biophysics analysis, efficiently patenting strategies of allosteric inhibition of PCSK9 for lipid decreasing, in addition to managing the scientific due diligence for 2 separate main out-licensing transactions.”
Dr. Bourne holds eight granted patents, with two others issuing later this 12 months, has co-authored eight revealed manuscripts and introduced eight abstracts at nationwide conferences.
Dr. Bourne acquired his M.S. in Scientific Investigation and his Ph.D. in Physiology, Biophysics and Programs Biology from Cornell College’s Weill Graduate College of Medical Sciences in New York. He subsequently accomplished his postdoctoral coaching on the Weill Medical School and at present holds an adjunct analysis college appointment on the Hospital for Particular Surgical procedure in New York Metropolis. Previous to that, Dr. Bourne served as an Adjunct Lecturer within the Division of Biology on the State College of New York School at Geneseo.
“Birch BioMed is growing thrilling immunomodulatory applied sciences which have the potential to grow to be life-changing remedies for regenerative medication. I’m honored to affix the workforce to proceed advancing these discoveries by way of scientific growth,” mentioned Dr. Bourne.
BirchBioMed, a College of British Columbia (UBC) spinoff, holds the unique worldwide pharmaceutical license for 2 medical therapeutic applied sciences from UBC that mark important medical breakthroughs within the remedy of fibrosis and sure autoimmune illnesses.
In January, BirchBioMed introduced constructive topline knowledge from its section 2 trials of FS2 for the remedy of mature keloid scars. The outcomes confirmed statistically important enchancment versus the market main scar cream.